OHSU in the news

FDA approves Rinvoq for atopic dermatitis: The details

Medical News Today February 22, 2022
Dr. Eric L. Simpson, MCR, a professor of dermatology and director of clinical research in the Department of Dermatology at Oregon Health & Science University in Portland, explains in a National Eczema Association webinar: “JAK inhibitors all improve itch rapidly within days, the skin rash, and the quality of life. For some of these severe patients, it can be extremely helpful. [However,] if they have a history of blood clots, history of cancer, or a history of severe infection needing hospitalization, I may not use a JAK inhibitor.”

Rinvoq: How does it work?

Medical News Today February 22, 2022
Dr. Eric Simpson, M.C.R., a professor of dermatology and director of clinical research in the Department of Dermatology at Oregon Health & Science University in Portland, outlines the role of cytokines in atopic dermatitis during a National Eczema Association webinar. “Cytokines […] are chemical messengers that your immune system uses […] to tell other cells to coordinate a response to an invader, and, unfortunately, in eczema, your immune system thinks you’re being invaded […] all the time.”

February is American Heart Month

KATU-TV February 22, 2022
Nandita Gupta, M.D., discusses why women are at higher risk for heart disease and how to prevent the condition.

Frightening and mysterious illness affects some regular marijuana users

KPTV February 21, 2022
A mysterious illness called cannabinoid hyperemesis syndrome affecting some regular, long-term marijuana users. Matt Noble, M.D., says: "There is so much about this condition that we still do not know, and I think there’s considerable scientific research left to be done."

Frightening and mysterious illness affects some regular marijuana users

KPTV February 21, 2022
In coverage about Cannabinoid Hyperemesis Syndrome, which causes some long-term marijuana users to experience uncontrollable vomiting and extreme stomach pain, Matt Noble, M.D., says: “There is so much about this condition that we still do not know, and I think there’s considerable scientific research left to be done.”

Who is dying of COVID amid omicron surge and widespread vaccine availability?

ABC News February 21, 2022
Mostly unvaccinated individuals are dying during the omicron variant-driven surge. David Zonies, M.D., says: "We started [in 2020] with the most vulnerable deaths among the elderly. As we transitioned into different variants, the age demographic shifted. Now we see very young people dying. It's around 30-year-olds and 40-year-olds"
See more stories